Diagnostics firm Thyrocare technologies Ltd on Monday (February 3) reported a 24% year-on-year (YoY) increase in net profit at ₹19.1 crore for the third quarter that ended December 31, 2024, compared to ₹15.4 crore in the same period in FY24.
| Company | Value | Change | %Change |
|---|
Revenue from operations was up 23.2% to ₹165.9 crore against ₹134.7 crore in the corresponding period of the preceding fiscal.
Also Read: Gateway Distriparks Q3 Results | Net profit rockets 7-fold to ₹456 crore, declares dividend
At the operating level, EBITDA surged 32.4% to ₹41.7 crore in the third quarter of this fiscal over ₹31.5 crore YoY.
The EBITDA margin stood at 25.1% in the reporting quarter versus 23.4% in the year-ago quarter. EBITDA is earnings before interest, tax, depreciation, and amortisation.
The results came after the close of the market hours. Shares of Thyrocare Technologies Ltd ended at ₹787.80, down by ₹10.25, or 1.28%, on the BSE.
Also Read: Alembic Pharma Q3 Results | Net profit declines 23% to ₹138 crore, net sales up 4%
